Correction to “Recent Cutting‐Edge Designing Strategies for Mtb‐DHFR Inhibitors as Antitubercular Agents”
Chemical Biology & Drug Design · 2026-07 · 108 (1)
DOI: 10.1111/cbdd.70357 ↗At a glance
Korrektur in Chemical Biology & Drug Design, published online on 2026-07-09.
Abstract (original language)
Sonawane, N. G., Thakur, A., Pillai, A. K. S., Sharma, A., Gunjal, A. P., & Sharma, K. (2024). “Recent Cutting-Edge Designing Strategies for Mtb-DHFR Inhibitors as Antitubercular Agents.” Chemical Biology & Drug Design 104, no. 6: e70027. The affiliation of the authors Nitin Govind Sonawane, Amrita Thakur, Anil Kumar Sasidharan Pillai, and Amol Pandurang Gunjal was incorrect and has been corrected to Department of Physical Sciences, Amrita School of Engineering, Amrita Vishwa Vidyapeetham, Bengaluru Campus, India. The online version of this article has been corrected accordingly. We apologize for this error.
Cite
APA
(2026). Correction to “Recent Cutting‐Edge Designing Strategies for Mtb‐DHFR Inhibitors as Antitubercular Agents”. Chemical Biology & Drug Design, 108(1). https://doi.org/10.1111/cbdd.70357
Vancouver
Correction to “Recent Cutting‐Edge Designing Strategies for Mtb‐DHFR Inhibitors as Antitubercular Agents”. Chemical Biology & Drug Design. 2026;108(1). doi:10.1111/cbdd.70357
BibTeX
@article{euvimed2026,
title = {Correction to “Recent Cutting‐Edge Designing Strategies for Mtb‐DHFR Inhibitors as Antitubercular Agents”},
journal = {Chemical Biology & Drug Design},
year = {2026},
volume = {108},
number = {1},
doi = {10.1111/cbdd.70357}
}
EUVIMED